Navigation Links
Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
Date:10/3/2007

pment & Chief Medical Officer. "The 28-day endpoint will provide meaningful data on early viral kinetics and the proportion of patients who have undetectable HCV RNA by the end of this treatment period. We look forward to sharing the preliminary results of this combination study in the first quarter of 2008 and making plans for future studies of R7128."

About Pharmasset

Pharmasset is a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, an oral treatment for chronic HBV infection, is in Phase 3 clinical trials for registration in the Americas and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a Phase 1 clinical trial through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

About R7128

R7128 is being developed for the treatment of chronic HCV infection. R7128 is a prodrug of PSI-6130, a pyrimidine nucleoside analog inhibitor of HCV RNA polymerase. Results from an oral single ascending dose study of PSI-6130 in 24 healthy male volunteers showed that PSI-6130 was generally well tolerated with no serious adverse events in doses up to 3000 mg.

R7128 Phase 1 Study Overview

The Phase 1 clinical trial is a multiple center, observer-blinded, randomized and placebo-controlled study to investigate the pharmacokinetics, pharmacodynamics, safety, tolerability and food effect of R7128 in healthy volunteers and in patients chr
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
2. Pharmasset Announces Clevudine and Hepatitis C Presentations at EASL
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
7. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results Demonstrate Safety and Efficacy at Once-Weekly Dosing
10. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
11. Active Biotechs I-3D Micro-dosing Clinical Trial Concluded
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CVS Health Corporation (NYSE: CVS ) ... 1, 2015, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call will ... the CVS Health website for all interested parties. To ... will be archived and available on the web site ...
(Date:4/17/2015)... ASSESS shows   plasma circulating tumour DNA ... to tumour biopsy   IGNITE supports value ...   AstraZeneca today presented results from two key ... testing for epidermal growth factor receptor (EGFR) mutation status in ... in clinical practice. [ 1 ] , ...
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... of the "Mammography Equipment - Global Strategic Business ... report analyzes the worldwide markets for Mammography Equipment in ... Equipment, and Digital Mammography Equipment. The report provides separate ... , Japan , Europe ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... , ... 1 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE Amex: ... medicine ("TCM") based in Chengdu, China, today,announced that it ... Drug,Administration (SFDA) to produce Pediatric Fever and Cough Oral ...
... 1 Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical ... injection, USP and ceftriaxone for injection, USP. Both are antibiotics ... gram-negative bacteria. Sagent will launch ceftriaxone in a 10 g ... by Sagent in July 2008. Cefoxitin 1 g and ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2
(Date:4/18/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Physical Therapy Association Annual Conference to be held ... Greenville, SC. , The SCAPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable ... Celebration on April 20 with a day full of ... and soul. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... Week is observed every April and highlights the communities ...
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3
... transient ischaemic attack (TIA), sometimes referred to as a "mini ... in the first year if their care was co-ordinated by ... a study published in the November issue of the ... Department of Neurology at Aarhus University Hospital in Denmark studied ...
... THURSDAY, Oct. 27 (HealthDay News) -- Older people who ... greater risk for complications and disability following surgery, according ... of Colorado said surgeons should assess the elderly differently ... when determining surgical risks. "This approach may lead ...
... found that a childhood behavioral intervention to lower dietary ... consumption of foods that are good sources of dietary ... and lower systolic blood pressure when study participants were ... publication in The Endocrine Society,s Journal of Clinical ...
... therapy was found to be ineffective in reducing ... lupus erythematosus (SLE). Results of the Atherosclerosis Prevention ... in Arthritis & Rheumatism , a journal ... College of Rheumatology (ACR), report that the statin ...
... doctors at the University of California, San Francisco indicates that a ... a study reported in the Oct. 27, 2011 issue of ... less common than other forms of the disease in the United ... is particularly common among men who have sex with men and ...
... By Alan Mozes HealthDay Reporter , WEDNESDAY, ... promises of popular probiotic yogurts to the test and found ... metabolized. But whether that means probiotic foods and supplements ... "Federal regulatory agencies are increasingly interested in evaluating all ...
Cached Medicine News:Health News:Hospital team significantly reduced risk of further vascular events after 'mini strokes' 2Health News:Hospital team significantly reduced risk of further vascular events after 'mini strokes' 3Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 2Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 3Health News:Childhood diet lower in fat and higher in fiber may lower risk for chronic disease in adulthood 2Health News:Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients 2Health News:Clinical trial shows first evidence that anal cancer is preventable 2Health News:Clinical trial shows first evidence that anal cancer is preventable 3Health News:Science Probes How Probiotic Yogurts Affect Your Gut 2Health News:Science Probes How Probiotic Yogurts Affect Your Gut 3
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
... A small portable unit weighing less ... offers extreme dependability and uncompromising image quality. ... this system is a cost effective solution ... EUB-405s sealed keyboard is durable and easy ...
The EUB-525 is a mid-size system with a full feature set. Capable of B-mode, M-mode, Doppler, Color Flow and Color Angiography it performs a variety of tasks in a simple and straightforward fashion....
... 6500 high resolution digital ultrasound ... enhanced operating efficiency, and remarkable ... and versatile configuration that simply ... in a variety of real-world, ...
Medicine Products: